AURADVANX

Swiss trademark · 781626 · Word mark · In force

Register entry

Registration number
781626
Application number
06872/2022
Status
In force
Type
Word mark
Filed
May 19, 2022
Registered
May 21, 2022
Published
May 21, 2022
Protected until
May 19, 2032
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Vorbeugung und Behandlung von Atemwegserkrankungen und -beschwerden.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 2, 2024

    Holder’s address changed

    Owner
    Sandoz AG, Lichtstrasse 35, 4056 Basel → Sandoz AG, Viaduktstrasse 3, 4051 Basel

    Published in Swissreg on 02.08.2024

  2. Oct 24, 2023

    Agent removed

    Representative
    Keller Schneider Patent- und Markenanwälte AG, Beethovenstrasse 49, Postfach, 8027 Zürich (removed)

    Published in Swissreg on 24.10.2023

  3. Oct 24, 2023

    Transferred

    Owner
    Novartis AG, 4002 Basel → Sandoz AG, Lichtstrasse 35, 4056 Basel

    Published in Swissreg on 24.10.2023

  4. May 21, 2022

    Registered

    Published in Swissreg on 21.05.2022

Parties

Holder

Sandoz AG

Viaduktstrasse 3, 4051 Basel

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.